The extended review for Elinzanetant is supported by data from the Phase III OASIS 1, 2, and 3 trials, which supported the ...

The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German ...

The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...

Gusttavo netted a fifth 10 minutes after the restart, at which point Ten Hag made another wave of changes. On came Edmond ...

Bayer says this is just the beginning, with 240,000 additional credits in the pipeline and expected to be issued as carbon credits later this year. A regenerative tonne is equal to approximately ...

Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside.

There was a ceiling,” he said. "I saw the chance to do something different—something I could shape from scratch.” ...

Together, Bayer and Corteva now control approximately 70% of the corn and soybean seed market in the U.S., a significant increase from around 40% two decades ago, according to USDA data.

An independent playing philosophy, full-time coaches and the long-term objective of the first-team squad: With a new ...